Approval · Notice of Compliance 28302 · 2022
SPIKEVAX: Notice of Compliance 28302
Issued June 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28302
- Date
- June 1, 2022
- Company
- Modernatx, Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Introduction of a new presentation and updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPIKEVAX | Not yet assigned | — |
Medicinal ingredients
- ELASOMERAN 1.26 MG per VIAL
- ELASOMERAN 0.32 MG per VIAL